MEDICINE DETAILS
Ajovy
Active ingredient: Fremanezumab Vfrm
Neutral reference profile for an independent medicine-access consultancy enquiry about Ajovy (Fremanezumab Vfrm). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Ajovy used for?
Ajovy (fremanezumab-vfrm) is indicated for the preventive treatment of migraine in adults.
Approved presentations:
Injection: 225 mg/1.5 mL single-dose prefilled syringe
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Ajovy identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
225 mg · 1 pen Catalogue organisation: Teva GmbH
-
225 mg · 1 pre-filled syringe Catalogue organisation: Teva GmbH
-
225 mg · 3 pens Catalogue organisation: Teva GmbH
-
225 mg solution for injection · 3 pre-filled syringes Catalogue organisation: CC Pharma GmbH
OFFICIAL SOURCES
Check the Ajovy record at an official source.
Search for “Ajovy” or “Fremanezumab Vfrm”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Ajovy.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Ajovy
01What is Ajovy?＋
This directory record associates the brand name Ajovy with the active ingredient Fremanezumab Vfrm. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Ajovy strengths and packs are recorded?＋
The catalogue currently shows: 225 mg · 1 pen; 225 mg · 1 pre-filled syringe; 225 mg · 3 pens; 225 mg solution for injection · 3 pre-filled syringes. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Ajovy?＋
Catalogue records currently name: Teva GmbH, CC Pharma GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Ajovy?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Ajovy, payment request, stock guarantee or binding offer.
06Can I buy Ajovy from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.